Literature DB >> 2844149

Human kidney cathepsins B and L. Characterization and potential role in degradation of glomerular basement membrane.

W H Baricos1, Y Zhou, R W Mason, A J Barrett.   

Abstract

Cathepsins B and L were purified from human kidney. SDS/polyacrylamide-gel electrophoresis demonstrated that cathepsins B and L, Mr 27000-30000, consist of disulphide-linked dimers, subunit Mr values 22000-25000 and 5000-7000. The pH optimum for the hydrolysis of methylcoumarylamide (-NHMec) substrates (see below) is approx. 6.0 for each enzyme. Km and kcat. are 252 microM and 364s-1 and 2.2 microM and 25.8 s-1 for the hydrolysis of Z-Phe-Arg-NHMec (where Z- represents benzyloxycarbonyl-) by cathepsins B and L respectively, and 184 microM and 158 s-1 for the hydrolysis of Z-Arg-Arg-NHMec by cathepsin B. A 10 min preincubation of cathepsin B (40 degrees C) or cathepsin L (30 degrees C) with E-64 (2.5 microM) results in complete inhibition. Under identical conditions Z-Phe-Phe-CHN2 (0.56 microM) completely inhibits cathepsin L but has little effect on cathepsin B. Incubation of glomerular basement membrane (GBM) with purified human kidney cathepsin L resulted in dose-dependent (10-40 nM) GBM degradation. In contrast, little degradation of GBM (less than 4.0%) was observed with cathepsin B. The pH optimum for GBM degradation by cathepsin L was 3.5. Cathepsin L was significantly more active in degrading GBM than was pancreatic elastase, trypsin or bacterial collagenase. These data suggest that cathepsin L may participate in the lysosomal degradation of GBM associated with normal GBM turnover in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844149      PMCID: PMC1149139          DOI: 10.1042/bj2520301

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

Review 1.  Proteinases in connective tissue breakdown.

Authors:  D J Etherington
Journal:  Ciba Found Symp       Date:  1979

Review 2.  The permeability properties of the lysosomal membrane.

Authors:  D J Reijngoud; J M Tager
Journal:  Biochim Biophys Acta       Date:  1977-11-14

Review 3.  [The ultrastructure of bone (report) (author's transl)].

Authors:  R K Schenk
Journal:  Verh Dtsch Ges Pathol       Date:  1974

4.  The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters.

Authors:  R Eisenthal; A Cornish-Bowden
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

5.  Rat glomerular basement membrane composition and metabolism in aminonucleoside nephrosis.

Authors:  E Blau; A F Michael
Journal:  J Lab Clin Med       Date:  1971-01

Review 6.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  Renal glomerular basement membrane. In vivo biosynthesis and turnover in normal rats.

Authors:  M P Cohen; M Surma
Journal:  J Biol Chem       Date:  1980-03-10       Impact factor: 5.157

8.  Studies on the metabolism of the renal glomerular basement membrane. Turnover measurements in the rat with the use of radiolabeled amino acids.

Authors:  R G Price; R G Spiro
Journal:  J Biol Chem       Date:  1977-12-10       Impact factor: 5.157

9.  Lysosomal cysteine proteinases.

Authors:  H Kirschke; J Langner; S Riemann; B Wiederanders; S Ansorge; P Bohley
Journal:  Ciba Found Symp       Date:  1979

10.  The degradation of human glomerular basement membrane with purified lysosomal proteinases: evidence for the pathogenic role of the polymorphonuclear leucocyte in glomerulonephritis.

Authors:  M Davies; A J Barrett; J Travis; E Sanders; G A Coles
Journal:  Clin Sci Mol Med       Date:  1978-03
View more
  16 in total

1.  An approach to computer-aided inhibitor design: application to cathepsin L.

Authors:  S Sudarsanam; G D Virca; C J March; S Srinivasan
Journal:  J Comput Aided Mol Des       Date:  1992-06       Impact factor: 3.686

Review 2.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

3.  Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis.

Authors:  R Kalluri; C F Shield; P Todd; B G Hudson; E G Neilson
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

4.  Expression of cysteine protease inhibitors in human gliomas and meningiomas.

Authors:  M Sivaparvathi; I McCutcheon; R Sawaya; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

5.  Increased proteinase expression during tumor progression of cell lines down-modulated for TIMP levels: a new transformation paradigm? [corrected].

Authors:  R Khokha; P Waterhouse; P Lala; M Zimmer; D T Denhardt; R Khokka
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 6.  Cathepsin B and its endogenous inhibitors: the role in tumor malignancy.

Authors:  B F Sloane; K Moin; E Krepela; J Rozhin
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

7.  Molecular and biochemical characterization of a cathepsin B-like protease family unique to Trypanosoma congolense.

Authors:  Carlos Mendoza-Palomares; Nicolas Biteau; Christiane Giroud; Virginie Coustou; Theresa Coetzer; Edith Authié; Alain Boulangé; Théo Baltz
Journal:  Eukaryot Cell       Date:  2008-02-15

8.  Cyclosporine A induced histological changes of Cathepsin L and CD2AP expression in renal glomeruli and tubules.

Authors:  Keisuke Sugimoto; Tomoki Miyazawa; Takuji Enya; Kouhei Miyazaki; Mitsuru Okada; Tsukasa Takemura
Journal:  Clin Exp Nephrol       Date:  2016-03-14       Impact factor: 2.801

Review 9.  Proteinases and the glomerulus: their role in glomerular diseases.

Authors:  M Davies; G A Coles; G J Thomas; J Martin; D H Lovett
Journal:  Klin Wochenschr       Date:  1990-11-16

10.  Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas.

Authors:  M Sivaparvathi; M Yamamoto; G L Nicolson; Z L Gokaslan; G N Fuller; L A Liotta; R Sawaya; J S Rao
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.